Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Unknown 3Completed 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Neoplasms 183Breast Neoplasms 174Carcinoma, Non-Small-Cell Lung 173Colorectal Neoplasms 105Stomach Neoplasms 81Pancreatic Neoplasms 79Lung Neoplasms 79Prostatic Neoplasms 77Melanoma 68Neoplasm Metastasis 67Recurrence 66Leukemia, Myeloid, Acute 66Multiple Myeloma 64Ovarian Neoplasms 62Carcinoma, Hepatocellular 62Lymphoma 61Advanced Solid Tumor 61Advanced Solid Tumors 56Solid Tumor 50Uterine Cervical Neoplasms 48Lymphoma, Non-Hodgkin 48Glioblastoma 44Lymphoma, B-Cell 40Leukemia 39Colonic Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Head and Neck Neoplasms 33Esophageal Neoplasms 32Urinary Bladder Neoplasms 30Sarcoma 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Advanced Tumor × Clear all
NCT05839106 2023-05-06

Phase I/IIa Study for PM1032 in the Treatment of Patients With Advanced Solid Tumors

Biotheus Inc.

Phase 1/2 Unknown
200 enrolled

Advanced Tumor

NCT05108779 2023-03-28

QLF32004 Injection for the Treatment of Patients With Advanced Malignant Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 1 Unknown
40 enrolled

Advanced Tumor

NCT05607563 2023-02-08

A Study of PM1009 (Anti-TIGIT/PVRIG) in Patients With Advanced Tumours

Biotheus Inc.

Phase 1 Unknown
54 enrolled

Advanced Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡